top of page
SACRIX
Titanium Triangular Implant
LEASTâ„¢
Less Exposure Advanced Spine Technologies
Incidence
22% of patients with low back pain and 43% with prior lumbar fusion suffer from SI Joint Pain
Sacroiliac Joint Fixation
Sacrix invented the 100% fluoroscopic percutaneous lateral-oblique sacroiliac joint fusion technique and patented the titanium implant technologies.
FDA-Approved since 2015
Indications For Use
The Sacrix® Sacroiliac Joint Fusion Device System is indicated for transfixation of the sacroiliac joint to achieve fusion for conditions including sacroiliac joint disruptions and degenerative sacroiliitis.
AVOIDS THE GLUTEAL MUSCLES, NERVES AND VESSELS
SACRIX FEATURES
COMPETITION
TECHNIQUE
PRODUCT CATALOG
CODING & BILLING
CASES
0% Device failure or loosening of Sacrix
UNILATERAL
Adjacent SIJ breakdown after lumbar fusion
BILATERAL
SUPPORTING ILIAC SCREWS
SUPPORTING ILIAC SCREWS
SACROPLASTY
AVOID DOING THESE CASES
Direct posterior intra-articular implants are unknowingly misplaced into the sacrum or ilium, only seen on CT scans
Study shows you need three implants for direct lateral SIJ, not two
REVISIONS
Revision Failed Direct Lateral SI-BONE iFuse Wedges
Revision Failed Direct Lateral Genesys SIros Screws
bottom of page